Search Results

Information Technology Facilitates Cost-Effectiveness Analysis in Developing Countries: An Observational Study of Breast Cancer Chemotherapy in Taiwan

Authors: >Ya-Chen Tina Shih,; Pan, I-Wen; Tsai, Yi-Wen

Source: PharmacoEconomics, Volume 27, Number 11, 1 November 2009 , pp. 947-961(15)

Publisher: Adis International

Anthracycline/docetaxel regimens come at a cost

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 12-12(1)

Publisher: Adis International

The Predictive Role of E-cadherin and Androgen Receptor on In Vitro Chemosensitivity in Triple-negative Breast Cancer

Authors: Koo, Ja Seung; Jung, Woohee; Jeong, Joon

Source: Japanese Journal of Clinical Oncology, Volume 39, Number 9, 11 September 2009 , pp. 560-568(9)

Publisher: Oxford University Press

Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents

Authors: Takeshita, Takashi; Wu, Wenwen; Koike, Ayaka; Fukuda, Mamoru; Ohta, Tomohiko

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 1039-1046(8)

Publisher: Springer

Weekly Administration of Docetaxel and Epirubicin as First-Line Treatment for Hormone-Refractory Prostate Carcinoma

Authors: Neri, B.; Molinara, E.; Pantaleo, P.; Rangan, S.; Crisci, A.; Della Melina, A.; Raugei, A.; Villari, D.; Nicita, G.

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 17, Numbers 11-12, 2009 , pp. 565-570(6)

Publisher: Cognizant Communication Corporation

Antineoplastics: Osteonecrosis and osteomyelitis (first report with epirubicin): case report

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 6-6(1)

Publisher: Adis International

Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept

Authors: Laihia, Jarmo K.; Pylkkänen, Liisa; Laato, Matti; Boström, Peter J.; Leino, Lasse

Source: BJU International, Volume 104, Number 9, November 2009 , pp. 1233-1238(6)

Publisher: Blackwell Publishing

Preoperative weekly cisplatinepirubicinpaclitaxel with G-CSF support in triple-negative large operable breast cancer

Authors: Frasci, G.; Comella, P.; Rinaldo, M.; Iodice, G.; Di Bonito, M.; D'Aiuto, M.; Petrillo, A.; Lastoria, S.; Siani, C.; Comella, G.; D'Aiuto, G.

Source: Annals of Oncology, Volume 20, Number 7, 10 July 2009 , pp. 1185-1192(8)

Publisher: Oxford University Press

Presentation, Management and Outcome of 32 Patients with Pregnancy-Associated Breast Cancer: A Matched Controlled Study

Authors: Halaska, Michael J.; Pentheroudakis, George; Strnad, Pavel; Stankusova, Hana; Chod, Jiri; Robova, Helena; Petruzelka, Lubos; Rob, Lukas; Pavlidis, Nicholas

Source: The Breast Journal, Volume 15, Number 5, September/October 2009 , pp. 461-467(7)

Publisher: Blackwell Publishing

Epirubicin/ifosfamide: Myelodysplastic syndrome: case report

Source: Reactions, Volume 1, Number 1263, 2009-08-01 , pp. 17-17(1)

Publisher: Adis International

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

Authors: OMalley, F. P.; Chia, S.; Tu, D.; Shepherd, L. E.; Levine, M. N.; Bramwell, V. H.; Andrulis, I. L.; Pritchard, K. I.

Source: Journal of the National Cancer Institute, Volume 101, Number 9, 6 May 2009 , pp. 644-650(7)

Publisher: Oxford University Press

Variations in Gene Expression and Response to Neoadjuvant Chemotherapy in Breast Carcinoma

Authors: Boidot, Romain; Vegran, Frederique; Soubeyrand, Marie-Sophie; Fumoleau, Pierre; Coudert, Bruno; Lizard-Nacol, Sarab

Source: Cancer Investigation, Volume 27, Number 5, June 2009 , pp. 521-528(8)

Publisher: Informa Healthcare

The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up

Authors: Colleoni, M.; Sun, Z.; Martinelli, G.; Basser, R. L.; Coates, A. S.; Gelber, R. D.; Green, M. D.; Peccatori, F.; Cinieri, S.; Aebi, S.; Viale, G.; Price, K. N.; Goldhirsch, A.

Source: Annals of Oncology, Volume 20, Number 8, 22 August 2009 , pp. 1344-1351(8)

Publisher: Oxford University Press

Drug eruption due to intravesical instillations of both epirubicin and mitomycin C

Authors: OKUMURA, Akiou; OISHI, Naoto; KAJI, Kenzo; IMAMURA, Tomoyoshi; FUSE, Hideki

Source: Journal of Dermatology, Volume 36, Number 7, July 2009 , pp. 419-422(4)

Publisher: Blackwell Publishing

Antineoplastics: Acute myeloid leukaemia: 11 case reports

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 7-7(1)

Publisher: Adis International

Epirubicin: Ulcer and necrosis following extravasation: case report

Source: Reactions, Volume 1, Number 1259, 2009-07-04 , pp. 16-16(1)

Publisher: Adis International

Dual potency anti-HER2/neu and anti-EGFR anthracycline immunoconjugates in chemotherapeutic-resistant mammary carcinoma combined with cyclosporin A and verapamil P-glycoprotein inhibition

Authors: Coyne, C. P.; Ross, Matt; Bailey, John

Source: Journal of Drug Targeting, Volume 17, Number 6, July 2009 , pp. 474-489(16)

Publisher: Informa Healthcare

Antineoplastics: Paroxysmal atrial fibrillation in an elderly patient: case report

Source: Reactions, Volume 1, Number 1255, 2009-06-06 , pp. 8-8(1)

Publisher: Adis International

Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer

Authors: HOY, Julia; NEEMAN, Teresa; STUART-HARRIS, Robin; DAVIS, Alison

Source: Asia-Pacific Journal of Clinical Oncology, Volume 5, Number 2, June 2009 , pp. 129-136(8)

Publisher: Blackwell Publishing

Genetic alterations and chemosensitivity profile in newly established human renal collecting duct carcinoma cell lines

Authors: Wu, Zheng-Sheng; Lee, Ju-Han; Kwon, Jung-Ah; Kim, Seo-Hee; Han, Sun-Hee; An, Jung-Suk; Lee, Ji-Hye; Lee, Eung-Seok; Park, Heum-Rye; Kim, Young-Sik

Source: BJU International, Volume 103, Number 12, June 2009 , pp. 1721-1728(8)

Publisher: Blackwell Publishing